Latest filing published 18 Jul 2013 for Omthera Pharmaceuticals, Inc., €350k.
No signal scores available.
Filings by Bernardus N. M. Machielse span 2 companies, the busiest being Omthera Pharmaceuticals, Inc. and Medimmune Inc /DE. Between 1 June 2007 and 18 July 2013, the trades on record add up to 4 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 18 July 2013, the filings show an option exercise worth €350k in Omthera Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations